Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age
Journal of the Pediatric Infectious Diseases Society · 2025
DOI: 10.1093/jpids/piaf067 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Sonia M McAlister und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wesfarmers Centre of Vaccines & Infectious Disease, The Kids Research Institute Australia, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, 6…. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Diphtheria-Tetanus-acellular Pertussis Vaccines, Immunity, Maternally-Acquired, Immunization Schedule. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Foundation for Children.
Abstract (Originalsprache)
We assessed the impact of maternally derived pertussis antibodies on infant responses to a 2 + 1 vaccine schedule (6 weeks, 12 weeks, and 12 months). Infants with baseline antibodies showed lower IgG responses following the primary vaccination series, but this did not impair booster responses at 4 years of age. Clinical Trials: The study is registered on the Australian New Zealand Clinical Trials Registry – www.anzctr.org.au (Part 1: ACTRN12615000898550, Part 2: ACTRN12622001216707).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wesfarmers Centre of Vaccines & Infectious Disease, The Kids Research Institute Australia, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, 6009, WA, Australia.
- School of Medicine, The University of Western Australia, Queen Elizabeth II Medical Centre, 17 Monash Avenue, Nedlands, 6009, WA, Australia.
- National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia.
- Centre for Child Health Research, The University of Western Australia, Perth, WA, Australia.
- The Children's Hospital at Westmead, Westmead, NSW, Australia.
- The University of Sydney, Sydney, NSW, Australia.
Förderung
- Foundation for Children
Zitieren
APA
McAlister, S. M., Dierig, A., van den Biggelaar, A. H. J., Thornton, R., Cooper, M. N., McIntyre, P., Richmond, P. C., & Wood, N. (2025). Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf067
Vancouver
McAlister SM, Dierig A, van den Biggelaar AHJ, Thornton R, Cooper MN, McIntyre P, et al. Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf067
BibTeX
@article{McAlister2025,
author = {McAlister, Sonia M and Dierig, Alexandra and van den Biggelaar, Anita H J and Thornton, Ruth and Cooper, Matthew N and McIntyre, Peter and Richmond, Peter C and Wood, Nicholas},
title = {Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2025},
doi = {10.1093/jpids/piaf067}
}
EUVIMED